Novartis faces a new crisis. For CEO Vas Narasimhan, this time is different
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery | Fortune
Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as the new CEO of Novartis, effective February 1, 2018. We thank
CEO Vas Narasimhan tells employees Novartis' deal with Trump lawyer was a mistake he's determined to overcome | Fierce Pharma
Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash | Barron's
Novartis CEO Vas Narasimhan on M&a and Taking Earlier Risks on New Technology
Re)Focusing Big Pharma: Novartis CEO Vasant Narasimhan with Jim Cramer at Healthy Returns
Novartis CEO Sees 'Better Place' With Covid by Year-End - Bloomberg
Vas Narasimhan (@VasNarasimhan) / Twitter
It was never my plan to be the boss of a huge company' - BBC News
Novartis on Twitter: "Today we announce Vas Narasimhan as new Novartis CEO from Feb 1, 2018. Thank you 👏 Joe Jimenez for your achievements https://t.co/2VauFSX2Be https://t.co/80YIKxip4I" / Twitter
The 'student' of leadership who seeks to inspire his employees | Financial Times
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Vasant Narasimhan | Novartis
Novartis names Indian-origin Vasant Narasimhan as new CEO | Mint
Novartis CEO Vasant Narasimhan on China's coronavirus outbreak
Novartis working on pan-coronavirus oral treatment, CEO says | Reuters